Madrigal Pharmaceuticals, Inc. (MDGL)
NASDAQ: MDGL · Real-Time Price · USD
517.26
+3.67 (0.71%)
At close: May 22, 2026, 4:00 PM EDT
513.00
-4.26 (-0.82%)
After-hours: May 22, 2026, 7:38 PM EDT
Madrigal Pharmaceuticals Stock Forecast
Stock Price Forecast
The 14 analysts that cover Madrigal Pharmaceuticals stock have a consensus rating of "Strong Buy" and an average price target of $674.36, which forecasts a 30.37% increase in the stock price over the next year. The lowest target is $550 and the highest is $964.
Price Target: $674.36 (+30.37%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Madrigal Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 8 | 8 | 8 | 8 | 6 |
| Buy | 4 | 5 | 5 | 5 | 5 | 6 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 14 | 14 | 14 | 14 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Strong Buy Maintains $640 → $709 | Strong Buy | Maintains | $640 → $709 | +37.07% | May 13, 2026 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $587 → $578 | Strong Buy | Maintains | $587 → $578 | +11.74% | May 7, 2026 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $652 → $649 | Buy | Maintains | $652 → $649 | +25.47% | May 7, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $620 | Strong Buy | Reiterates | $620 | +19.86% | May 6, 2026 |
| B of A Securities | B of A Securities | Hold Maintains $570 → $529 | Hold | Maintains | $570 → $529 | +2.27% | Feb 20, 2026 |
Financial Forecast
Revenue This Year
1.54B
from 958.40M
Increased by 60.16%
Revenue Next Year
2.30B
from 1.54B
Increased by 49.64%
EPS This Year
-6.68
from -12.85
EPS Next Year
11.05
from -6.68
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 1.7B | 2.8B | ||||||
| Avg | 1.5B | 2.3B | ||||||
| Low | 1.4B | 1.9B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 74.7% | 83.3% | ||||||
| Avg | 60.2% | 49.6% | ||||||
| Low | 44.6% | 22.9% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -3.34 | 18.99 | ||||||
| Avg | -6.68 | 11.05 | ||||||
| Low | -11.61 | 2.19 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.